alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 74, Number 114 (Tuesday, June 16, 2009)]
[Notices]
[Page 28574]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-14055]


-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice (09-052)]


Government-Owned Inventions, Available for Licensing

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of availability of inventions for licensing.

-----------------------------------------------------------------------

SUMMARY: Patent applications on the inventions listed below assigned to 
the National Aeronautics and Space Administration, have been filed in 
the United States Patent and Trademark Office, and are available for 
licensing.

DATES: June 16, 2009.

FOR FURTHER INFORMATION CONTACT: Bryan A. Geurts, Patent Counsel, 
Goddard Space Flight Center, Mail Code 140.1, Greenbelt, MD 20771-0001; 
telephone (301) 286-7351; fax (301) 286-9502.
    NASA Case No. GSC-15421-1: Spring Joint with Overstrain Sensor;
    NASA Case No. GSC-15557-1: System and Method for Embedding Emotion 
in Logic Systems;
    NASA Case No. GSC-15458-1: System and Method for Transferring 
Telemetry Data Between a Ground Station and a Control Center;
    NASA Case No. GSC-15001-1: Apparatus and Method for a Light 
Direction Sensor.

    Dated: June 10, 2009.
Richard W. Sherman,
Deputy General Counsel.
[FR Doc. E9-14055 Filed 6-15-09; 8:45 am]
BILLING CODE P
#### Philip Seldon, Appellant, v Andrew Spinnell, Respondent.

Submitted March 4, 2013;

decided April 2, 2013

Motion for reargument of motion for leave to appeal denied with $100 costs and necessary reproduction disbursements *[see*20 NY3d 857 (2013)]. Cross motion for the imposition of sanctions denied.

Judge Rivera taking no part.
II 

111TH CONGRESS 

2D SESSION S. 3246 

To exclude from consideration as income under the Native American Housing 

Assistance and Self-Determination Act of 1996 amounts received by 

a family from the Department of Veterans Affairs for service-related 

disabilities of a member of the family. 

IN THE SENATE OF THE UNITED STATES 

APRIL 22, 2010 

Mr. WYDEN (for himself and Mr. THUNE) introduced the following bill; which 

was read twice and referred to the Committee on Indian Affairs 

A BILL 

To exclude from consideration as income under the Native 

American Housing Assistance and Self-Determination 

Act of 1996 amounts received by a family from the 

Department of Veterans Affairs for service-related disabilities of a member of the family. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Indian Veterans Hous5 ing Opportunity Act of 2010’’. 


jbell on DSKDVH8Z91PROD with BILLS
2 

•S 3246 IS

1 SEC. 2. EXCLUSION FROM INCOME. 

2 Paragraph (9) of section 4 of the Native American 

3 Housing Assistance and Self-Determination Act of 1996 

4 (25 U.S.C. 4103(9)) is amended by adding at the end the 

5 following new subparagraph: 

6 ‘‘(C) Any amounts received by any member 

7 of the family as disability compensation under 

8 chapter 11 of title 38, United States Code, or 

9 dependency and indemnity compensation under 

10 chapter 13 of such title.’’. 

Æ 


jbell on DSKDVH8Z91PROD with BILLS
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of General Medical Sciences; Special Emphasis Panel; ZGM1 MORE-1 BB.                    

*Date:*                         July 9, 2009.                    

*Time:*                         8:30 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, MD 20814.                    

*Contact Person:*                         Helen R. Sunshine, PhD, Chief, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, Natcher Building 45, Room 3AN12F, Bethesda, MD 20892, 301-594-2881,                         *sunshinh@nigms.nih.gov.*

                        (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88,                               ( print page 28053)                            Minority Access to Research Careers; 93.96, Special Minority Initiatives, National Institutes of Health, HHS)                    

Dated: June 4, 2009.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. E9-13756 Filed 6-11-09; 8:45 am]

BILLING CODE 4140-01-M
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                              16
<SECURITIES>                                         0
<RECEIVABLES>                                     3302
<ALLOWANCES>                                         0
<INVENTORY>                                        204
<CURRENT-ASSETS>                                  3575
<PP&E>                                            7436
<DEPRECIATION>                                  (4782)
<TOTAL-ASSETS>                                    6952
<CURRENT-LIABILITIES>                             3475
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         14486
<OTHER-SE>                                     (11093)
<TOTAL-LIABILITY-AND-EQUITY>                      6952
<SALES>                                           2367
<TOTAL-REVENUES>                                  2367
<CGS>                                             2190
<TOTAL-COSTS>                                     4443
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  20
<INCOME-PRETAX>                                 (2096)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                             (2096)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    (2096)
<EPS-BASIC>                                     (0.16)
<EPS-DILUTED>                                   (0.16)



</TABLE>
EXHIBIT 99.1
                                                                    ------------

                  CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350



            In connection with the Quarterly Report of CECS CORP. (the
"Company") on Form 10-Q for the period ended June 30, 2002, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Valerie
A. Broadbent, President and Chief Executive Officer of the Company, hereby
certify pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2002, that:

          (1) the Report fully complies with the requirements of section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and

          (2) the information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

/s/ Valerie A. Broadbent
------------------------------------
Valerie A. Broadbent
President and Chief Executive Officer
August 16, 2002
[Federal Register Volume 74, Number 107 (Friday, June 5, 2009)]
[Notices]
[Pages 27045-27046]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-13106]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF THE INTERIOR

Bureau of Land Management

[LLORL00000-L10200000.MJ0000.LXSS021H0000; HAG 09-0201]


Notice of Meeting, Southeast Oregon Resource Advisory Council 
(Oregon)

AGENCY: Bureau of Land Management, Interior.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: Pursuant to the Federal Land Policy and Management Act and the 
Federal Advisory Committee Act, the U.S. Department of the Interior, 
Bureau of Land Management (BLM) Southeast Oregon Resource Advisory 
Council (SEORAC) will meet as indicated below:

DATES: The meeting will begin at 7 p.m. on July 1, 2009.

ADDRESSES: The Council will meet by teleconference. For a copy of the 
material to be discussed and/or the conference call number, please 
contact Scott Stoffel; information below.

FOR FURTHER INFORMATION CONTACT: Scott Stoffel, Public Affairs 
Specialist, 1301 South G Street, Lakeview, OR 97630, (541) 947-6237.

SUPPLEMENTARY INFORMATION: The SEORAC advises the Secretary of the 
Interior, through the BLM, on a variety

[[Page 27046]]

of planning and management issues for public lands in the Lakeview, 
Burns and Vale BLM Districts and the Fremont-Winema and Malheur 
National Forests. The Council will conduct a public meeting by 
teleconference on July 1, 2009 to discuss and come to consensus on the 
contents of comments to be sent to the BLM's Oregon/Washington State 
Director on the Draft Environmental Impact Statement for Vegetation 
Treatments Using Herbicides on BLM Lands in Oregon. The public is 
welcome to listen to the entire teleconference and make oral comments 
to the Council from 7:45 p.m. to 8 p.m.

    Dated: May 27, 2009.
Carol A. Benkosky,
District Manager, Lakeview District Office.
[FR Doc. E9-13106 Filed 6-4-09; 8:45 am]
BILLING CODE 4310-33-P
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Labor

###### Employment and Training Administration

          - [TA-W-65,858]

In accordance with Section 221 of the Trade Act of 1974, as amended, an investigation was initiated on April 28, 2009 in response to a worker petition filed on behalf of workers of Schnadig Corporation, Des Plaines, Illinois.

The petitioner has requested that the petition be withdrawn. Consequently, the investigation has been terminated.

Signed in Washington, DC, this 7th day of May 2009.

Richard Church,

Certifying Officer, Division of Trade Adjustment Assistance.

[FR Doc. E9-13912 Filed 6-12-09; 8:45 am]

BILLING CODE 4510-FN-P
Exhibit 11

                   Computation of Net Income Per Common Share

<TABLE>
<CAPTION>
                                                       Three Months Ended       Six Months Ended
                                                            March 31,               March 31,
                                                       ------------------      ------------------
                                                        1998        1997        1998        1997
                                                       ------      ------      ------      ------
<S>                                                     <C>         <C>         <C>         <C>
(In thousands, except per share amounts)

BASIC:
Weighted average shares outstanding                     7,114       4,309       6,349       4,305
                                                       ------      ------      ------      ------
Total                                                   7,114       4,309       6,349       4,305
                                                       ======      ======      ======      ======
Net income                                             $  397      $  405      $  284      $  445
                                                       ======      ======      ======      ======
Net income per share                                   $ 0.06      $ 0.09      $ 0.04      $ 0.10
                                                       ======      ======      ======      ======
DILUTED:
Weighted average shares outstanding                     7,114       4,309       6,349       4,305
Conversion of 1,703 shares of preferred stock
  into 1,023 shares of common stock                        --       1,023          --       1,023

Assuming exercise of options and warrants reduced
  by the number of shares which could have been
  purchased with the proceeds from such exercise          529         479         530         479
                                                       ------      ------      ------      ------
Total                                                   7,643       5,811       6,879       5,807
                                                       ======      ======      ======      ======
Net income                                             $  397      $  405      $  284      $  445
                                                       ======      ======      ======      ======
Net income per share                                   $ 0.05      $ 0.07      $ 0.04      $ 0.08
                                                       ======      ======      ======      ======
</TABLE>
[Federal Register Volume 74, Number 113 (Monday, June 15, 2009)]
[Notices]
[Page 28259]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-13946]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Team Science in 
Diabetes, Endocrinology, and Metabolic Diseases.
    Date: July 28, 2009.
    Time: 1 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call)
    Contact Person: Robert Wellner, PhD, Scientific Review Officer, 
Review Branch, DEA, NIDDK, National Institutes of Health, Room 757, 
6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-4721, 
<a href="/cdn-cgi/l/email-protection#196b6e282e2c6e59777071377e766f"><span class="__cf_email__" data-cfemail="2a585d1b1d1f5d6a444342044d455c">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: June 8, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-13946 Filed 6-12-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
**EXHIBIT 99.1**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER****PURSUANTTO****SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002****(18 U.S.C. 1350)**

In connection with the Quarterly Report of Wells Real Estate Fund II-OW (the“Registrant”) on Form 10-Q for the three month period ended September 30, 2002, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Leo F. Wells, III, Chief Executive Officerof the corporate General Partner of the Registrant, hereby certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350), that, to the best of his knowledge and belief:

         (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

|                                                                                                                           |   |   |   |
|---------------------------------------------------------------------------------------------------------------------------|--------|--------|--------|
| /s/ LEO F. WELLS,III  **Leo F. Wells, III****Chief Executive Officer****November 13, 2002**   20 |
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration
 By Notice dated January 9, 2009, and published in the 
                    **Federal Register**
                     on January 21, 2009 (74 FR 3643), Mallinckrodt Inc., 3600 North Second Street, St. Louis, Missouri 63147, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Drug
ScheduleTetrahydrocannabinols (7370)
ICodeine-N-oxide (9053)
IDihydromorphine (9145)
IDifenoxin (9168)
IMorphine-N-oxide (9307)
INormorphine (9313)
INorlevorphanol (9634)
IAmphetamine (1100)
IIMethamphetamine (1105)
IIMethylphenidate (1724)
IINabilone (7379)
IICodeine (9050)
IIDiprenorphine (9058)
IIEtorphine HCL (9059)
IIDihydrocodeine (9120)
IIOxycodone (9143)
IIHydromorphone (9150)
IIDiphenoxylate (9170)
IIEcgonine (9180)
IIHydrocodone (9193)
IILevorphanol (9220)
IIMeperidine (9230)
IIMethadone (9250)
IIMethadone intermediate (9254)
IIMetopon (9260)
IIDextropropoxyphene, bulk (9273)
IIMorphine (9300)
IIOripavine (9330)
IIThebaine (9333)
IIOpium extracts (9610)
IIOpium fluid extract (9620)
IIOpium tincture (9630)
IIOpium, powdered (9639)
IIOpium, granulated (9640)
IILevo-alphacetylmethadol (9648)
IIOxymorphone (9652)
IINoroxymorphone (9668)
IIAlfentanil (9737)
IIRemifentanil (9739)
IISufentanil (9740)
IIFentanyl (9801)
II
 The firm plans to manufacture the listed controlled substances for internal use and for sale to other companies. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Mallinckrodt Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Mallinckrodt Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: June 3, 2009. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.


[FR Doc. E9-13356 Filed 6-8-09; 8:45 am] BILLING CODE 4410-09-P
#### Cincinnati Bar Association *v.*Stern.

[Cite as *Cincinnati Bar Assn. v. Stern*(1997), 78 Ohio St.3d 533.]

(No. 96-2784

Submitted February 19, 1997

Decided June 11, 1997.)

*534
      *James C. Crowley IV*and *Kevin L. Swiek,*for relator.

*Per Curiam.*

We concur with the findings, conclusions, and recommendation of the board. Respondent is indefinitely suspended from the practice of law in Ohio. Costs taxed to respondent.

*Judgment accordingly.*

Moyer, C.J., Douglas, Resnick, F.E. Sweeney, Pfeifer, Cook and Lundberg Stratton, JJ., concur.